Market Place
Sourcing Support
WPD to Receive $6.7 M Grant for Development of Annamycin Drug Candidate
11 May 2021 //
GLOBENEWSWIRE
WPD to Attend the 10th Congress of the Polish Society of Pediatric Oncology
27 Apr 2021 //
GLOBENEWSWIRE
WPD Pharmaceuticals Announces Amended Sublicense Agreement with Moleculin
30 Mar 2021 //
GLOBENEWSWIRE
WPD and CNS Announce Positive Opinion of the Polish Central WPD-201
18 Feb 2021 //
GLOBENEWSWIRE
WPD Enters into Collaborative Agreement for WP1122, Receives Supply
17 Aug 2020 //
GLOBENEWSWIRE
CNS & WPD Identify Leading Polish Medical Institutions for Berubicin Ph2 Trial
30 Apr 2020 //
PRNEWSWIRE
CNS Announces Shareholder Webinar to Discuss Collaboration with WPD Pharma
15 Apr 2020 //
PR NEWSWIRE
WPD Pharma Reports Active Compound in Licensed Drug Candidate Reduces Coronaviru
09 Apr 2020 //
GLOBBENEWSWIRE
CNS Pharma Signs Agreement with WPD Pharmaceuticals to Develop Drug Candidates
23 Mar 2020 //
PR NEWSWIRE
WPD Pharmaceuticals` STAT3 Inhibitor Received FDA Approval of IND Status
20 Feb 2020 //
GLOBENEWSWIRE
WPD Pharmaceuticals to Conduct Clinical Trials in Pediatric Brain Tumors
12 Feb 2020 //
PRESS FRELAESE
WPD Pharma Completed the Acquisition of Two Drug Candidates $100 Million
03 Feb 2020 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.